Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential prognostic impact of cytopenic phenotype in prefibrotic vs overt primary myelofibrosis.

Blood cancer journal - 12 Aug 2022

Coltro Giacomo, Mannelli Francesco, Loscocco Giuseppe Gaetano, Mannarelli Carmela, Rotunno Giada, Maccari Chiara, Pancani Fabiana, Atanasio Alessandro, Vannucchi Alessandro Maria, Guglielmelli Paola

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Bone Marrow
Share to Eosinophilic Disorders and Syndromes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Share to Phenotype

Share to Primary Myelofibrosis

Share to Prognosis

Share to Thrombocythemia, Essential

Source

Open in PubMed Open full text

Identifiers

PMID: 35961958
DOI: 10.1038/s41408-022-00713-6
PMCID: PMC9374751

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential prognostic impact of cytopenic phenotype in prefibrotic vs overt primary myelofibrosis.PMID 35961958Read ↗

Prefibrotic versus overtly fibrotic primary myelofibrosis: clinical, cytogenetic, molecular and prognostic comparisonsSemantic proximity Read ↗

Evidence that prefibrotic myelofibrosis is aligned along a clinical and biological continuum featuring primary myelofibrosis.Semantic proximity Read ↗

Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease.Semantic proximity Read ↗

Essential thrombocythemia vs. early/prefibrotic myelofibrosis: why does it matter.Semantic proximity Read ↗

Thrombocytosis Phenotype in Prefibrotic Primary Myelofibrosis: Risk Stratification and Prognostic Significance.Semantic proximity Read ↗

Myeloproliferative neoplasms: Morphology and clinical practiceSemantic proximity Read ↗

U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions.Semantic proximity Read ↗

AEL transformed from post-ET myelofibrosis with a sinusoidal pattern, JAK2 mutation, and biallelic TP53 inactivation.Semantic proximity Read ↗

Myelofibrotic transformations of polycythemia vera and essential thrombocythemia are morphologically, biologically, and prognostically indistinguishable from primary myelofibrosis.Semantic proximity Read ↗

Clinicopathologic characteristics of prefibrotic-early primary myelofibrosis in Chinese patients.Semantic proximity Read ↗

Morphologic and cytogenetic differences between post-polycythemic myelofibrosis and primary myelofibrosis in fibrotic stage.Semantic proximity Read ↗

A 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic MyelofibrosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.